Literature DB >> 8958530

Management of eyelid sebaceous carcinomas.

M Dogru1, H Matsuo, M Inoue, K Okubo, M Yamamoto.   

Abstract

We retrospectively studied 14 patients confirmed histopathologically to have eyelid sebaceous carcinoma during 1986-1994. We removed all tumors totally with frozen section controls and performed reconstruction either by primary apposition or transposition flaps. We observed recurrence in 5 patients (35.7%) in whom a surgical margin of either 1 or 3 mm was taken but none in those with a 5-mm surgical margin. At least 5 mm of normal tissue around the tumor should be removed considering the metastatic potential of these tumors.

Entities:  

Mesh:

Year:  1997        PMID: 8958530     DOI: 10.1159/000310872

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

Review 1.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

2.  Locally aggressive and multicentric recurrent extraocular sebaceous carcinoma: case report and literature review.

Authors:  Advaith Bongu; Edward S Lee; Stephen R Peters; Ravi J Chokshi
Journal:  Eplasty       Date:  2013-08-21

3.  Analysis of hedgehog signaling in periocular sebaceous carcinoma.

Authors:  John C Bladen; Mariya Moosajee; Dhani Tracey-White; Michèle Beaconsfield; Edel A O'Toole; Michael P Philpott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-08       Impact factor: 3.117

4.  Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients.

Authors:  Yoshiaki Takagawa; Wakana Tamaki; Shigenobu Suzuki; Koji Inaba; Naoya Murakami; Kana Takahashi; Hiroshi Igaki; Yuko Nakayama; Naoyuki Shigematsu; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

5.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.